XML 39 R142.htm IDEA: XBRL DOCUMENT v2.4.0.6
OPERATING SEGMENTS AND GEOGRAPHIC AREAS (Schedule of Operating Segments) (Details) (USD $)
In Millions, unless otherwise specified
 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2011
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Electronic and Functional Materials [Member]
Dec. 31, 2010
Electronic and Functional Materials [Member]
Dec. 31, 2009
Electronic and Functional Materials [Member]
Dec. 31, 2011
Coatings and Infrastructure Solutions [Member]
Dec. 31, 2010
Coatings and Infrastructure Solutions [Member]
Dec. 31, 2009
Coatings and Infrastructure Solutions [Member]
Dec. 31, 2011
Agricultural Sciences [Member]
Dec. 31, 2010
Agricultural Sciences [Member]
Dec. 31, 2009
Agricultural Sciences [Member]
Dec. 31, 2009
Performance Materials [Member]
Dec. 31, 2011
Performance Materials [Member]
Dec. 31, 2010
Performance Materials [Member]
Dec. 31, 2009
Performance Materials [Member]
Dec. 31, 2011
Performance Plastics [Member]
Dec. 31, 2010
Performance Plastics [Member]
Dec. 31, 2009
Performance Plastics [Member]
Dec. 31, 2011
Feedstocks and Energy [Member]
Dec. 31, 2010
Feedstocks and Energy [Member]
Dec. 31, 2009
Feedstocks and Energy [Member]
Dec. 31, 2011
Corporate [Member]
Dec. 31, 2010
Corporate [Member]
Dec. 31, 2009
Corporate [Member]
Segment Reporting Information [Line Items]                                                    
Sales to external customers   $ 59,985 $ 53,674 $ 44,875 $ 4,599 $ 4,203 $ 3,074 $ 7,200 $ 6,596 $ 5,598 $ 5,655 $ 4,869 $ 4,522   $ 14,647 $ 13,957 $ 11,780 $ 16,257 $ 15,260 $ 12,862 $ 11,302 $ 8,457 $ 6,346 $ 325 $ 332 $ 693
Intersegment revenues   0 [1] 0 [1] 0 [1] 0 [1] 0 [1] 0 [1] 0 [1] 9 [1] 0 [1] 0 [1] 0 [1] 0 [1]   91 [1] 97 [1] 76 [1] 0 [1] 2 [1] 0 [1] 23 [1] 37 [1] 27 [1] (114) [1] (145) [1] (103) [1]
Equity in earnings of nonconsolidated affiliates   1,223 1,112 630 104 106 79 321 343 215 4 2 2   (31) 16 46 303 254 101 561 407 195 (39) (16) (8)
Goodwill impairment loss   0 0 7 [2]     0 [2]     0 [2]     0 [2] 7     7 [2]     0 [2]     0 [2]     0 [2]
Restructuring charges   0 26 [3] 689 [3]   8 [3] 48 [3]   20 [3] 262 [3]   0 [3] (15) [3]     0 [3] 2 [3]   0 [3] 1 [3]   0 [3] 140 [3]   (2) [3] 251 [3]
IPR&D   0 0 7 [4]     0 [4]     0 [4]     0 [4]       0 [4]     0 [4]     0 [4]     7 [4]
Acquisition and integration related expenses 31 31 [5] 143 [5] 166 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5]   0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 0 [5] 31 [5] 143 [5] 166 [5]
Asbestos-related credits   0 (54) [6] 0   0 [6]     0 [6]     0 [6]       0 [6]     0 [6]     0 [6]     (54) [6]  
EBITDA   7,785 [7] 7,200 [7] 4,828 [7] 1,084 [7] 1,052 [7] 654 [7] 1,167 [7] 1,230 [7] 604 [7] 913 [7] 640 [7] 573 [7]   1,748 [7] 1,714 [7] 1,568 [7] 3,440 [7] 3,565 [7] 2,120 [7] 940 [7] 471 [7] 477 [7] (1,507) [7] (1,472) [7] (1,168) [7]
Assets   69,224 69,588 66,018 11,386 11,642 11,164 11,935 12,447 11,827 5,746 5,528 5,477 11,092 10,936 11,376 11,092 11,583 12,634 12,294 5,116 5,412 5,542 12,522 10,549 8,622
Investment in nonconsolidated affiliates   3,405 3,453 3,224 350 357 307 1,104 1,099 1,068 50 42 38 263 198 167 263 1,376 1,602 1,517 127 97 9 200 89 22
Depreciation and amortization   2,883 2,962 2,827 439 448 344 548 638 540 167 147 137   635 627 696 754 760 733 212 216 242 128 126 135
Capital expenditures   $ 2,687 $ 2,130 $ 1,683 $ 247 $ 221 $ 97 $ 365 $ 239 $ 238 $ 352 $ 245 $ 166   $ 567 $ 621 $ 576 $ 251 $ 202 $ 90 $ 886 $ 602 $ 473 $ 19 $ 0 $ 43
[1] Includes revenues generated by transfers of product to Agricultural Sciences from other segments, generally at market-based prices. Other transfers of products between operating segments are generally valued at cost.
[2] See Note I for information regarding the goodwill impairment loss.
[3] See Note C for information regarding restructuring charges.
[4] See Note D for information regarding purchased in-process research and development.
[5] See Note D for information regarding acquisition and integration related expenses.
[6] See Note N for information regarding the asbestos-related credit.
[7] A reconciliation of EBITDA to “Income from Continuing Operations Before Income Taxes” is provided below.